Does amylin have a pathophysiological endocrine role in diabetes mellitus in man?
Baxter
M A
MA
St. Peter's Hospital, Chertsey, Surrey, Great Britain.
Barnett
A H
AH
D000682:Amyloid / Q000502:physiology*; D000818:Animals; D003920:Diabetes Mellitus / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D006801:Humans; D058228:Islet Amyloid Polypeptide; D008954:Models, Biological; D058287:Receptors, Islet Amyloid Polypeptide; D018000:Receptors, Peptide / Q000502:physiology; D015290:Second Messenger Systems
D000682:Amyloid; D058228:Islet Amyloid Polypeptide; D058287:Receptors, Islet Amyloid Polypeptide; D018000:Receptors, Peptide